RKDA (Arcadia Biosciences) Marketable Securities : $0.00 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Arcadia Biosciences Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Arcadia Biosciences's Marketable Securities for the quarter that ended in Dec. 2024 was $0.00 Mil.

Arcadia Biosciences's annual Marketable Securities increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($5.12 Mil) but then declined from Dec. 2023 ($5.12 Mil) to Dec. 2024 ($0.00 Mil).

Arcadia Biosciences Marketable Securities Historical Data

The historical data trend for Arcadia Biosciences's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arcadia Biosciences Marketable Securities Chart

Arcadia Biosciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Marketable Securities

Get a 7-Day Free Trial

11.63

5.12

Arcadia Biosciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Marketable Securities	Get a 7-Day Free Trial															5.12	5.18	2.60	2.64	-

Arcadia Biosciences Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Arcadia Biosciences (NAS:RKDA) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Arcadia Biosciences Marketable Securities Related Terms

Thank you for viewing the detailed overview of Arcadia Biosciences's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Arcadia Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Arcadia Biosciences Inc (NAS:RKDA) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

5950 Sherry Lane, Suite 215, Dallas, TX, USA, 75225

Website

https://www.arcadiabio.com

Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, and others.

Executives

Thomas J. Schaefer	officer: Chief Financial Officer	202 COUSTEAU PLACE STE 105, DAVIS CA 95618
Stanley Jr Jacot	officer: Chief Executive Officer	202 COUSTEAU PLACE STE 105, DAVIS CA 95618
Pamela Haley	officer: Chief Financial Officer	202 COUSTEAU PLACE, DAVIS CA 95618
Laura Pitlik	officer: Chief Marketing Officer	202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Chris Cuvelier	officer: Chief Growth Officer	202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Deborah D Carosella	director	3603 HAVEN AVE, SUITE E, MENLO PARK CA 94025
Matthew T Plavan	officer: Chief Financial Officer	C/O THERMOGENESIS CORP., 2711 CITRUS ROAD, RANCHO CORDOVA CA 95742
Randall Shultz	officer: Chief Technology Officer	4222 E. THOMAS ROAD, SUITE 320, PHOEBIIX AZ 85018
Sarah Reiter	officer: Chief Commercial Officer	202 COUSTEAU PLACE, DAVIS CA 95618
Lilian Shackelford Murray	director	228 BEACH ROAD, BELVEDERE CA 94920
Kevin Comcowich	director	C/O ARCADIA BIOSCIENCES, INC., 202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Albert D. Bolles	director	CONAGRA FOODS, INC., ONE CONAGRA DRIVE, MS 1-330, OMAHA NE 68102
Eric J. Rey	director, officer: President and CEO	ARCADIA BIOSCIENCES, INC., 202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Zhongjin Lu	officer: VP Product Development	ARCADIA BIOSCIENCES, INC., 202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Amy Yoder	director	C/O SPECTRUM BRANDS, INC., 6 CONCOURSE PARKWAY, SUITE 3300, ATLANTA GA 30328